Evaluation and Management of Worsening Thrombocytopenia

Immediate Laboratory Evaluation

The American Society of Hematology recommends obtaining a complete blood count with differential to assess current platelet count and identify isolated thrombocytopenia versus pancytopenia 1, 2, 3
A peripheral blood smear examination by a qualified hematologist or pathologist is necessary to exclude pseudothrombocytopenia and assess platelet size 1, 2, 3, 4
Reticulocyte count should be evaluated to assess for hemolysis 1, 5
Basic coagulation studies, such as PT, aPTT, fibrinogen, and D-dimer, should be performed to exclude disseminated intravascular coagulation if platelet count is severely reduced 3

A comprehensive drug history, including the specific blood pressure medication and timing of medication changes, should be taken to assess for potential drug-induced thrombocytopenia 1, 6, 3
Consider drug-induced thrombocytopenia if a temporal relationship exists between medication initiation and symptom worsening 3
Review all medications, including over-the-counter products and herbal supplements, to assess for potential causes of thrombocytopenia 4

If thrombocytopenia is confirmed and isolated, HIV and hepatitis C testing should be performed in all adults 1, 6, 3, 4
H. pylori testing should be considered where eradication may have clinical impact 1, 6, 3
Antinuclear antibodies should only be tested if clinical features suggest systemic lupus erythematosus 1, 6
Thyroid function tests and antithyroid antibodies should be performed as 8-14% of ITP patients develop thyroid disease 6
Bone marrow examination with aspirate and biopsy is indicated if age >60 years, systemic symptoms, abnormal hemoglobin or white blood cell parameters, or abnormal peripheral smear findings are present 1, 2, 6, 3
Flow cytometry and cytogenetic testing should accompany bone marrow examination to exclude myelodysplastic syndromes, leukemias, or lymphoproliferative disorders 1, 6, 3

Schistocytes on blood smear suggest thrombotic microangiopathy and require immediate evaluation, including ADAMTS13 testing, complement studies, LDH, haptoglobin, and direct antibody test 7, 5, 3
Fever, confusion, or renal dysfunction suggest thrombotic thrombocytopenic purpura or hemolytic uremic syndrome and require urgent evaluation 7, 5, 3
New thrombotic events despite thrombocytopenia suggest heparin-induced thrombocytopenia or antiphospholipid syndrome and require immediate evaluation 3
Platelet count <10 × 10³/μL indicates high risk of serious bleeding and requires urgent attention 2, 8
Active bleeding beyond petechiae requires immediate evaluation and management 2

Failing to exclude pseudothrombocytopenia before initiating extensive workup 1, 3, 4
Missing secondary causes of ITP, such as HIV, HCV, autoimmune diseases, or lymphoproliferative disorders 1, 6, 3
Overlooking inherited thrombocytopenias, such as MYH9-related disease or Bernard-Soulier syndrome 1, 6, 3
Delaying bone marrow examination in older patients (>60 years) where myelodysplastic syndromes are more common 1, 6, 3

Repeat focused physical examination to assess extent and distribution of petechiae and purpura, mucosal bleeding, hepatosplenomegaly or lymphadenopathy, skeletal abnormalities or dysmorphic features, and signs of systemic illness 1, 2, 6, 3

Obtain CBC and peripheral smear within 24-48 hours given progressive petechiae and history of thrombocytopenia 3
If platelet count <50 × 10³/μL, advise activity restrictions to avoid trauma-associated bleeding
If platelet count <20 × 10³/μL, consider hematology referral even without active bleeding 2
Weekly monitoring may be appropriate once diagnosis is established and patient is stable 3